David Jorden - Nov 28, 2025 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
CEO/CFO, Director
Signature
/s/ David Jorden
Stock symbol
AURX
Transactions as of
Nov 28, 2025
Transactions value $
-$300,000
Form type
4
Date filed
12/3/2025, 06:13 PM
Previous filing
Aug 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JORDEN DAVID EMERSON CEO/CFO, Director C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON /s/ David Jorden 2025-12-03 0001313516

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURX Common Stock Sale -$300K -200K -9.32% $1.50 1.95M Nov 28, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported herein was made in a private transaction to facilitate a personal real estate transaction whereby the shares of common stock acquired constitute "restricted" securities within the meaning of the Securities Act of 1933, as amended.